Chuangmei Pharmaceutical

I: Investor Relations

Announcements and Circulars

The current position: Home>Investor Relations>Announcements and Circulars

Year

2024
2023
2022
2021
2020
2019
2018
2017
2016
2015
2014

192022-05

CONTINUING CONNECTED TRANSACTIONS IN RELATION TO ENTERING INTO FRAMEWORK SALES AGREEMENT AND FRAMEWORK PURCHASES AGREEMENT AND NOTICE OF EXTRAORDINARY GENERAL MEETING
172022-05

CLOSURE OF REGISTER OF MEMBERS
042022-05

DELAY IN DESPATCH OF CIRCULAR
032022-05

Monthly Returns-Monthly Return of Equity Issuer on Movements in Securities for the month ended 30 April 2022
282022-04

FORM OF PROXY FOR USE AT THE ANNUAL GENERAL MEETING TO BE HELD AT THE CONFERENCE ROOM ON 3RD FLOOR, NO. 235 SONG SHAN NORTH ROAD, LONGHU DISTRICT, SHANTOU CITY, GUANGDONG PROVINCE, THE PRC ON 6 JUNE 2022 at 10 A.M. OR AT ANY ADJOURNMENT THEREOF
282022-04

NOTICE OF ANNUAL GENERAL MEETING
282022-04

2021 AGM CIRCULAR
282022-04

2021 Annual Report
112022-04

Supplemental Announcement Resignation of Director, Company Secretary and Chief Financial Officer
112022-04

CONTINUING CONNECTED TRANSACTIONS ENTERING INTO (1) FRAMEWORK SALES AGREEMENT AND(2) FRAMEWORK PURCHASES AGREEMENT
082022-04

List of directors and their roles and functions
082022-04

Resignation of Director, Company Secretary and Chief Financial Officer; Change in the Composition of Board Committees; Appointment of Joint Company Secretaries; Change in Authorized Representative; Appointment of Person-in-charge of Finance; and Waiver from Strict Compliance with Rules 3.28 and 8.17 of the Listing Rules

11 12 13 14 15

The Enterprise OA